HPR97 National Reimbursement Drug List Negotiation in China: Analysis of the Key Trends and Factors Influencing the Value Appraisal and Price Determination
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1227
https://www.valueinhealthjournal.com/article/S1098-3015(22)03432-5/fulltext
Title :
HPR97 National Reimbursement Drug List Negotiation in China: Analysis of the Key Trends and Factors Influencing the Value Appraisal and Price Determination
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03432-5&doi=10.1016/j.jval.2022.09.1227
First page :
Section Title :
Open access? :
No
Section Order :
10772